Area of research
Physiology · Surgery
Research interest
Research focused on Calcineurin and Left ventricular hypertrophy, with related work in Everolimus, Longevity, Fibroblast growth factor 23. Notable publications include 'Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy', 'Rapamycin extends murine lifespan but has limited effects on aging', and 'Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II'.
Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from 6 months after heart transplantation: The randomized MANDELA study
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II
Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
Performance of gene-expression profiling test score variability to predict future clinical events in heart transplant recipients
Rapamycin extends murine lifespan but has limited effects on aging
Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling
Everolimus in Heart Transplantation: An Update
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Physiology · Surgery →